Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023

BUY
$18.7 - $23.07 $3.28 Million - $4.05 Million
175,400 New
175,400 $3.53 Million
Q1 2022

May 16, 2022

SELL
$14.54 - $21.5 $1.45 Million - $2.15 Million
-100,000 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$26.01 - $38.22 $4.29 Million - $6.31 Million
-165,000 Reduced 62.26%
100,000 $3.2 Million
Q2 2019

Aug 14, 2019

BUY
$52.76 - $82.19 $3.43 Million - $5.34 Million
65,000 Added 32.5%
265,000 $0
Q1 2019

May 15, 2019

BUY
$27.39 - $68.41 $5.48 Million - $13.7 Million
200,000 New
200,000 $11.9 Million

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.